IL17A and arthritic joint disease: Intriguingly, we found that the arthritis clinical score decreased with the administration of an IL‐17A antagonist in CAIA mice, indicating that AS‐LTEV‐enclosed IL‐17A may play a role in maintaining the inflammatory microenvironment.